Analyst firms · J.P. Morgan · RAPT

J.P. Morgan RAPT price target and rating history

RAPT Therapeutics Inc. (RAPT) · Health Care

J.P. Morgan rates RAPT Therapeutics Inc. (RAPT) Underweight with a $15 price target, as of its latest action on Nov 11, 2024. It has published 3 rating actions on RAPT since December 2021, including 0 upgrades and 2 downgrades.

Current rating
Underweight
Price target
$15
Median target, all firms
Too few
Actions on RAPT
3

J.P. Morgan price target on RAPT

$61$38$1520222023202420252026
J.P. Morgan price target on RAPT, each point a stated target, December 2021 to February 2024.

Every J.P. Morgan rating on RAPT

Questions about J.P. Morgan and RAPT

What is J.P. Morgan's price target for RAPT?
J.P. Morgan's latest stated price target for RAPT Therapeutics Inc. (RAPT) is $15, from its action on Feb 21, 2024.
What is J.P. Morgan's rating on RAPT?
J.P. Morgan rates RAPT Underweight, a bearish rating, as of Nov 11, 2024.
When did J.P. Morgan last change its view on RAPT?
On Nov 11, 2024, J.P. Morgan downgrades to Underweight from Neutral.

More RAPT rating histories

All J.P. Morgan ratingsRAPT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.